Neuronetics(STIM)
MALVERN, PAMedical Devices
Focus: Neuronetics is a publicly traded medical device company specializing in transcranial magnetic stimulation (TMS) therapy for psychiatric and neurological disorders. With 5,000+ employees and $71M in revenue (FY 2025), it operates a geographically distributed network of treatment centers.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
30
Should You Work at Neuronetics?
AI assessmentNeuronetics offers stability in a niche, cash-flowing market but presents limited growth trajectory and profitability concerns for career-focused professionals seeking fast-scaling environments.
Why Work Here
- Market leader in TMS therapy with established NeuroStar platform generating $71M revenue with 9.2% YoY growth
- Geographically distributed clinical operations across 15+ regional centers provide diverse career paths in clinical, commercial, and operations roles
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$71M
Key Products
NeuroStar TMS Therapy System
Stable
Peak
Flagship FDA-cleared platform driving majority of revenue; multiple iterations (Advanced, Active) demonstrate incremental innovation.
Magstim RapidStim2
Help build intelligence for Neuronetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.